Retrophin Inc operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Retrophin Inc with three other
companies in this sector in UNITED STATES :
sales of $156.70 million
of which 72%
of which 50%
was Dried cannabis), and
Amicus Therapeutics, Inc
of which 100%
During the year ended December of 2019, sales at
Retrophin Inc were $175.34 million.
increase of 6.8%
versus 2018, when the company's sales were $164.25 million.
This was the fifth consecutive year of sales increases at Retrophin Inc
(and since 2014, sales have increased a total of 522%).